SARS-CoV-2, HIV and Hepatitis C - what do these viruses have in common? They can be targeted with antiviral medications, which have changed the way we’re able to manage these diseases, as well as prevent and control their spread. As we face the possibility of emerging and re-emerging infectious diseases, as well as the increase in antimicrobial-resistant strains, major questions arise when it comes to the viability of developing new antiviral agents. We explore whether cannabis compounds may offer promise, with food scientist Associate Professor Choo Wee Sim and molecular virologist Associate Professor Sharifah Syed Hassan.

Image Credit: Shutterstock Ai

Produced by: Tee Shiao Eek

Presented by: Tee Shiao Eek

This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  medical advances

Tags:  the bigger picture,  health & living,  antiviral,  hepatitis,  covid-19,  sars-cov-2,  medical cannabis,  infectious diseases,  hiv,  antimicrobial resistance,  cannabis,